MedPath

Impact of Dietary Counseling on Anthropometric Parameters, Antioxidant Nutrient Intake, and Metabolic Syndrome Parameters on Metabolic Syndrome Patients Attending Diet Therapy Clinic: A Pre-Post Non-Randomized Intervention Study.

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Registration Number
PACTR202303722531066
Lead Sponsor
Baba Suleman Aminu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
82
Inclusion Criteria

1. Eligible subjects were 18–70-year-old adults.
2. Patients who had been diagnosed with MetS The diagnostic criteria were based on at least three or more of the following characteristics of the MetS by NCEP-ATP III: Below are the diagnostic criteria
-Central obesity (waist circumference =102 cm for men and =88 cm for women).
-Elevated triglycerides =1.7 mmol/l (or on pharmacological therapy).
-Reduced HDL-cholesterol <1.0 mmol/l for men and <1.3 mmol/l for women - or on pharmacological therapy)
-Raised BP =130/85 mmHg (or on pharmacological therapy).
-Elevated fasting plasma glucose =5.6 mmol/l. (or on pharmacological therapy)
3. Patients who were receiving dietary counseling at Manhyia District Hospital (the intervention group) and those who were not receiving any dietary counseling but receiving their standard treatment at Ejisu Government Hospital (the control group).
4. Patients who gave their consent to be part of the study and were willing to follow a dietary
counseling regimen for three months.

Exclusion Criteria

Exclusion criteria included all those who;
1. Were below 18 years of age and did not meet the NCEP-ATP III criteria of MetS.
2. Were diagnosed with MetS less than a year ago and did not attend any of the hospitals under study.
3. Were non-ambulatory critically ill MetS patients whose conditions (from the patient hospital record book or folder) such as cancer, liver disease, asthma, and inflammatory disorders contribute immensely to oxidative stress.
4. MetS subjects with impaired memory or cognitive functions or the presence of mental illness causing an inability to give an appropriate or logical response to questions with the help of a psychiatrist.
5. Individuals with MetS who were on any antioxidant therapy or supplements one month prior to the study.
6. Refused to give their consent to be part of the study and refused to follow COVID-19 protocols.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath